ÂÜÀòÂÒÂ×

Tom Graney, CFA, currently serves as Board Member - Audit Chair for Notable and Mogrify, with a prior role as CEO and CFO of Oxurion NV. Graney has extensive experience in the biotechnology and pharmaceutical sectors, having held key financial leadership positions at AC Immune, Generation Bio, Vertex Pharmaceuticals, and Ironwood Pharmaceuticals. Prior to these roles, Graney was the Worldwide CFO for Ethicon at Johnson & Johnson, overseeing significant financial operations in global medical devices. Graney's expertise also includes positions at Tibotec and Janssen, along with academic contributions as an Adjunct Professor of Mergers and Acquisitions at New York University. Education includes an MBA from NYU Stern School of Business and a BS in Accounting from the University of Delaware.